Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2025

Britto LS, Balasubramani D, Desai S, Phillips P, Trehan N, Cesarman E, et al. T Cells Spatially Regulate B Cell Receptor Signaling in Lymphomas through H3K9me3 Modifications. Adv Healthc Mater. 2025;14(5):e2401192.

2024

Mueller FB, Yang H, Li C, Dadhania DM, Xiang JZ, Salvatore SP, et al. RNA-sequencing of Human Kidney Allografts and Delineation of T-Cell Genes, Gene Sets, and Pathways Associated With Acute T Cell-mediated Rejection. Transplantation. 2024;108(4):911-922.

Bergom HE, Sena LA, Day A, Miller B, Miller CD, Lozada JR, et al. Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer. NPJ Genom Med. 2024;9(1):7.

Hoellwarth JS, Reif TJ, Mori S, Kang R, Magro CM. Horrifying Basal Cell Carcinoma Presenting as Progressive Pyoderma Gangrenosum: Case Report. Case Rep Oncol. 2024;17(1):298-304.

Kim D, Thrall MJ, Michelow P, Schmitt FC, Vielh PR, Siddiqui MT, et al. The current state of digital cytology and artificial intelligence (AI): global survey results from the American Society of Cytopathology Digital Cytology Task Force. J Am Soc Cytopathol. 2024;13(5):319-328.

Yang HS. Machine Learning for Sepsis Prediction: Prospects and Challenges. Clin Chem. 2024;70(3):465-467.

Han Y, Duan X, Yang L, Nilsson-Payant BE, Wang P, Duan F, et al. Author Correction: Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature. 2024;630(8016):E7.

Caplan AS, Todd GC, Zhu YC, Sikora M, Akoh CC, Jakus J, et al. Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineae. JAMA Dermatol. 2024;160(7):701-709.

Li Y, Deng K, Kaner J, Geyer JT, Ouseph M, Fang F, et al. Detection of Hybrid Fusion Transcripts, Aberrant Transcript Expression, and Specific Single Nucleotide Variants in Acute Leukemia and Myeloid Disorders with Recurrent Gene Rearrangements. Pathobiology. 2024;91(1):76-88.

Sumiyoshi T, Wang X, Warner EW, Sboner A, Annala M, Sigouros M, et al. Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial. J Natl Cancer Inst. 2024;116(1):115-126.